Top Markets
Coin of the day
Defence Therapeutics Inc. Defence Therapeutics Inc.

Defence Therapeutics Inc.

DTC
Classement en actions #28139
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Prix de l'action
$0.37430781
Dernière synchronisation: 2026-08-19
Capitalisation boursière
$28.37M
Changement (1 jour)
2.00%
Changement (1 an)
-13.46%
Pays
CA
Échange Defence Therapeutics Inc. (DTC)

Catégorie

Historique du rendement du dividende pour Defence Therapeutics Inc. (DTC)
Le rendement du dividende (TTM) de Defence Therapeutics Inc. (symbole boursier : DTC) au 2026 est : 0
Rendement moyen du dividende sur les 5 dernières années : 0.00%
Historique du rendement du dividende de Defence Therapeutics Inc. (DTC) de 2026 à 2026
Rendement du dividende à la fin de chaque année (TTM)
Année Rendement du dividende Changez
Pas assez de données pour les dates fournies.
Rendements du dividende (TTM) pour des entreprises similaires ou concurrentes
Entreprise Rendement du dividende Pays
0.00%
US
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH